Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today we look at what happens when a state finally counts the cannabis workforce, while city councils, commissions, and courts move the goalposts on hemp, licensing, and equity. Michigan’s jobs math sits alongside Virginia’s adult use blueprint, Chicago’s hemp politics, and a set of rulings that show where federal patience is running out and where it is holding the line.
Today’s edition is supported by You.com and Superhuman AI. If you want your work in front of the same decision-makers, reply to this email and we will talk about advertising.
📊 Jobs, payrolls, and political leverage
🏛️ Hemp bans, licenses, and the courts
🧃 Drinking culture, hemp drinks, and new habits
Clear numbers and steady preparation rarely lose to panic.
Learn how to make every AI investment count.
Successful AI transformation starts with deeply understanding your organization’s most critical use cases. We recommend this practical guide from You.com that walks through a proven framework to identify, prioritize, and document high-value AI opportunities.
In this AI Use Case Discovery Guide, you’ll learn how to:
Map internal workflows and customer journeys to pinpoint where AI can drive measurable ROI
Ask the right questions when it comes to AI use cases
Align cross-functional teams and stakeholders for a unified, scalable approach

Start here — the day’s most important development, decoded for impact.
📌 What Happened: Michigan finally put hard numbers on the cannabis workforce. Crain’s, using Vangst and state data, estimates that roughly 52% of net new private sector jobs since 2018 tie back to cannabis, with more than 10,000 roles added in 2023 and annual sales north of $3 billion. Those jobs live in shops, grows, kitchens, labs, security firms, and back offices that look like every other small business in the state. Over the same stretch, lawmakers signed off on a 24% wholesale tax and treated cannabis as a convenient place to pull extra revenue. The assumption was simple: this is a profitable, politically soft industry that can take a hit and stay quiet. The jobs data land in a world where that assumption no longer looks safe.
💡 Why It Matters: We all knew the jobs were there, and the data are quantifiable if you wanted to count. Well, now its on paper. When an industry can show that more than half of recent private job growth flows through its ecosystem, tax hikes and new restrictions start to look like choices with visible local consequences. Members who backed the 24% rate likely thought they were trimming a still-marginal sector, not leaning on a major hiring engine that employers and workers can now point to by name and by headcount. The next budget cycle will be the first round of negotiations where everyone at the table has seen those workforce figures in a mainstream business outlet, not just in an industry slide deck. Knowledge is power, and these numbers should be used to persuade.
🧠 THC Group Take: This data needs to be put to work. Start by stripping the jargon out and putting faces to the math. These are not “FTEs” in a chart, they are the budtender who knows half the town by name, the trim worker paying off a used car, the lab tech who drops their kid at the same school as the local city council member. Put that on one page for every district, with headcount, payroll, and a few real roles people can picture, then carry it into every budget and tax conversation.
Show up with a short list of specific goals, for example stepping down the effective tax load, cleaning up one broken licensing or zoning choke point, or drawing a firmer line against new fees that nibble at margin. Each goal should be framed as a way to keep those neighbors on the job, not as a favor to “the industry.” When you bring owners, workers, and a local workforce or community college partner who can say “these are the folks we train and employ here,” you give electeds something more concrete than a sales figure.
The point is simple. If cannabis is supplying this many paychecks, it belongs in the same political conversation as any other major employer. Treat the jobs data as a roll call of voters and parents, then decide where you want to cash that in.

Fast-moving headlines, flagged for what matters.
Congress’s rider-based hemp THC ban is drawing fire from Texas editorial writers who say it was stapled onto a shutdown deal with none of the fact-finding the issue deserves. The board walks through how a 0.4 mg cap and a catchall on “similar” cannabinoids would function as a near-total wipeout of today’s intoxicating hemp market, including the THC beverage category now moving serious volume through big-box retailers, c-stores, and even Edible Arrangements. They acknowledge enforcement failures and bad actors who exploited the 2018 Farm Bill, then turn to the core complaint that Washington let the industry grow, did little to police it, and is now reaching for a blunt instrument that ignores state work and jobs. Texas lawmakers get rare praise as a counterexample, with the board arguing that Austin has treated hemp as a policy problem to solve rather than a mess to shove into an appropriations rider. The editorial reads like a warning shot from a conservative state that expects Congress to fix its own mess in daylight, not at the back of a spending bill. (The Dallas Morning News)
Chicago aldermen are advancing an ordinance that would effectively wipe out most intoxicating hemp sales in the city, even though Mayor Brandon Johnson pitched the sector as something to tax and regulate in his 2026 budget. Early summaries point toward a near-total prohibition on hemp-derived THC, layered on top of the new federal crackdown and aimed squarely at the unlicensed storefronts that have become a familiar neighborhood complaint. Johnson’s team had floated a $10 million hemp tax line item, which now looks like a political orphan if City Council opts for prohibition instead of licensing and inspections. The real tension sits between ward-level complaints and City Hall’s interest in jobs, filled storefronts, and a softer landing for operators who thought they were building legitimate businesses. If the ordinance passes close to its current form, the first test will be how quickly inspectors move on existing shops and how long the administration is willing to live with darkened windows where a new revenue line was supposed to be. (Crain’s Chicago Business)
Cheech & Chong’s Cannabis Company is trying to prove that licensing can beat ownership in a retail landscape tilted toward MSOs. The company has fifteen shops operating or in build-out across Montana, Oklahoma, Massachusetts, Maine, and Guam, and is chasing 100 branded locations in the next 12 to 18 months through a 6% royalty and full-store or shop-in-shop overlays. The pitch to independents is straightforward: keep the license and cap table, bolt on a national brand, Headset data, and marketing support that they say is driving a 20 to 30% lift at the register, plus a clearer path to an eventual exit. The model leans heavily on hemp beverages and edibles as a mass-retail onramp, which is why the team is spending time in Washington arguing that a federal hemp THC ban would push volume back into untracked markets and cut off a key acquisition funnel. The fine print is where any former regulator’s antenna goes up, because the covenants around brand standards, cash flow, and veto rights will decide whether this is a clean licensing play or a workaround to ownership and control limits that starts to look like de facto management in everything but name. (High Times)
A major Democratic turnout group is quietly telling its own base that cannabis is slipping out of the party’s hands. The Progressive Turnout Project is fundraising off a “Marijuana Decriminalization Advisory Board,” warning that President Trump and Republicans could “steal marijuana reform right out from under us” if Democrats keep moving slowly on legalization and equity bills. Their email leans on the MORE Act that House Democrats passed twice and frames GOP control of Congress and the White House as a direct threat to that agenda, even as some Republicans position cannabis as a public-safety and banking issue. The mechanics are standard list-building tactics, with a short survey and a donate button, yet the copy matters because it puts party anxiety about Trump’s rescheduling talk and Republican repositioning into plain language. That framing treats marijuana policy as contested terrain again, not a base issue Democrats can assume will sit quietly in their column. (Marijuana Moment)
Virginia’s Joint Commission on Cannabis has delivered a final framework that would launch adult-use sales on next November, just as governor-elect Abigail Spanberger arrives with a pro-legalization record. The plan eliminates local opt-out while giving cities and counties the ability to stack up to a 3.5% local tax on top of an 8% state rate, which turns municipal budget offices into quiet allies of implementation. It leans heavily on microbusinesses, reserves roughly half of initial licenses for small Virginia-based operators, and caps canopy to keep top-tier grows at 35,000 square feet. Existing medical operators can buy into the market with a $10 million conversion fee, a design choice that equity advocates say hands incumbents a head start while newer brands wait on the sidelines. Public comment already reflects the divide, with small producers warning they will be steamrolled by cheap flower unless lawmakers tighten guardrails around ownership limits and timing. The real work in the coming session will be how Spanberger and legislative leaders adjust those financial and structural levers once lobbyists start testing the edges of the blueprint. (Marijuana Moment)
Curaleaf has agreed to buy The Cannabist Company’s Virginia assets for about $110 million, a price that towers over Cannabist’s sub–$30 million market cap and underlines how investors value limited licenses in pre-adult-use states. The package includes five open dispensaries, one in development, and roughly 82,000 square feet of cultivation and production around Richmond, with $80 million in cash at closing, $20 million in deferred payments tied to adult-use sales, and a $10 million one-year note at 6% interest. A 15 day go-shop period and a $3.3 million break fee give Cannabist’s special committee nominal room to test the market while its broader strategic review continues. Curaleaf is effectively buying a structured option on Virginia’s eventual adult-use launch and matching the richest parts of its consideration to when that market actually opens. The spread between what a strategic buyer will pay for this footprint and what public investors are willing to pay for the stock is the number that tells you how distorted cannabis equity pricing has become. (New Cannabis Ventures)
Nebraska’s Medical Cannabis Commission just introduced two new members, Robert “Bud” Synhorst and James Elworth, which means every seat on the board is now handpicked by Gov. Jim Pillen. At the same meeting, medical marijuana advocates lined up to remind commissioners that 71% of voters approved these initiatives and warned that patience is running out for a program built on tight plant caps, bans on smokable and vape products, and narrow product rules. Manufacturers and patients keep pointing to Missouri’s open medical and adult-use systems as the likely outlet for Nebraskans who can travel if regulators do not widen access. Lawmakers have already accused the commission of overshooting its authority and missing statutory deadlines, which turns every new appointment into a referendum on whether the board intends to carry out the ballot language or keep constraining it. The quiet risk is a simmering mix of border trade, litigation, and political backlash while the commission continues to talk process in a state that has already voted for medical cannabis on paper. (Nebraska.tv)
A Los Angeles judge has refused to carve a Nevada-based plaintiff out of a gender discrimination suit targeting TRP Management, the largest licensee of Cookies branded stores. Five former employees say they were pushed out around 2022 so male colleagues could take their jobs, describing an executive “bro culture” and a product team where four women were let go in a supposed reduction while three men stayed and advanced. One plaintiff, a Black former marketing leader, alleges the company claimed to eliminate her role, then hired a man to do the same work and evaluated her performance through the lens of gender and race. TRP argued that plaintiff Brianna Zemel’s Nevada role had no California ties, yet the judge overruled the company’s bid to drop her claims and left the case on track for a 2027 trial. Months of discovery tied to a marquee brand have a way of dragging internal culture into the light in a way no marketing refresh can control. (MyNewsLA)
The Ninth Circuit has pressed pause on a closely watched dormant commerce clause challenge to Los Angeles’ cannabis social equity rules, asking the parties to explain what the case should look like now that other appellate courts have ruled in the same area. In Variscite v. City of Los Angeles, the plaintiffs argue that residency-tinted equity preferences illegally disadvantage out-of-state owners, while the city leans on federal illegality to say there is no lawful interstate cannabis market for the Constitution to protect. The panel’s stay comes against a backdrop of growing doctrinal tension, with the First and Second Circuits treating cannabis licensing rules like any other protectionist scheme and district courts in the Ninth Circuit saying dormant commerce clause principles stop at the edge of a federally banned market. That mix raises the odds that any eventual opinion will either deepen a circuit split or drag its own district courts toward a more uniform standard. Each month of delay leaves equity programs on a legal fault line that will not stay quiet forever. (Law360)
Chicago operators are turning the city’s drinking culture into a laboratory for low and no alcohol menus that now lean heavily on hemp-derived THC and CBD drinks. A new WBEZ / Sun-Times feature tracks how U.S. alcohol consumption has fallen to a 90 year low and how breweries, bars, and restaurants are filling the gap with kombuchas, spirit alternatives, ready to drink mocktails, and cannabinoid beverages that sit alongside traditional beer and wine. Ed Marszewski of Marz Community Brewing says a significant share of the brewery’s production is now nonalcoholic and credits that pivot with keeping his 35 person staff employed, while hemp-derived drinks account for roughly half of his business and generate millions in sales. He calls the recent federal spending bill that closes the 2018 hemp loophole a “hemp industry killer bill” that will end many businesses and put “hundreds of thousands” out of work, a warning that lands differently when tied to neighborhood jobs instead of abstract market size. The picture that emerges is a city where hemp beverages are not a novelty, but part of the scaffolding for how people drink when alcohol and policy both start to move. (WBEZ; Chicago Sun-Times)
A New York federal judge has held that the Saint Regis Mohawk Tribe cannot recover lost profits for cannabis sales under RICO because marijuana remains illegal at the federal level. The tribe had alleged that a web of nontribal competitors siphoned business from its dispensary through racketeering activity and sought treble damages for the lost revenue, pointing to New York’s legalization framework and its own sovereign authority over commerce on tribal land. The judge agreed that RICO permits claims for “business or property” injuries, but drew a hard line at profits tied to conduct Congress still classifies as criminal, even when state law and tribal rules say otherwise. The ruling sits uncomfortably next to recent Supreme Court guidance that broadened the kinds of economic harms that can qualify as RICO injuries, and it highlights a growing split between doctrines on paper and how lower courts treat cannabis-specific claims. Until Congress changes the schedule, even sophisticated tribal and state-legal businesses are likely to find federal courthouse doors only partially open when they try to monetize cannabis harms. (Law360)
Go from AI overwhelmed to AI savvy professional
AI will eliminate 300 million jobs in the next 5 years.
Yours doesn't have to be one of them.
Here's how to future-proof your career:
Join the Superhuman AI newsletter - read by 1M+ professionals
Learn AI skills in 3 mins a day
Become the AI expert on your team

From the hearing room to the comment section — we’re watching it all.
🩺 UK specialists now have a 189 page dosing handbook that turns scattered practice on cannabis oils into a single, structured set of starting doses, titration steps, and monitoring rules for twelve common conditions. It is a small but telling move toward professional self-regulation in a system where public coverage remains narrow and critics still describe prescribing as improvisation. (Cannabis Health News)
🎖️ A veterans nonprofit that has sent more than 100 former service members and first responders abroad for psychedelic assisted therapy just saw VA turn down its SSG Fox suicide-prevention grant application on threshold eligibility grounds. It is a neat snapshot of the gap between reform-friendly rhetoric in Washington and a grants bureaucracy that still treats unapproved drugs and offshore clinics as a bridge too far for federal dollars. (Marijuana Moment)
📉 Morningstar’s latest note on Tilray slaps the company with a “no moat” label and argues that its cannabis and alcohol lines both sit in crowded markets with thin pricing power and little defensible edge. The critique reads less like a hit piece and more like a reminder that stitching hard businesses together does not magically turn them into a franchise investors can rely on when the cycle turns. (Morningstar)





